Kimberly Gentile

Annual data

2018

In 2018, Kimberly Gentile earned a total compensation of $2.8M as SVP, Clinical Operations at Biohaven Pharmaceutical Holding Co Ltd..

Ranking3,446 out of 10,934
Percentile68.5%

Kimberly Gentile's 2018 compensation ranked 3,446th out of 10,934 executive pay records tracked by us this year.

Gentile earned more than 68.5% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking363 out of 1,246
Percentile70.9%

In the industry group of Drugs, Gentile's pay ranked 363rd out of 1,246 executive pay records tracked by us in 2018.

Gentile earned more than 70.9% of executives in this group.

Bonus$198,297
Option Awards$2,243,800
Salary$327,250
Other$15,192
Total$2,784,539

Gentile received $2.2M in option awards, which accounts for 80.58% of total compensation.

Gentile also received $198.3K in bonus, $327.3K in salary and $15.2K in other compensation.